Olivier Benvéniste

Prevalence of Serum IgG and Neutralizing Factors Against Adeno-Associated Virus (AAV) Types 1, 2, 5, 6, 8, and 9 in the Healthy Population: Implications for Gene Therapy Using AAV Vectors

Sylvie Boutin, Virginie Monteilhet, P. Véron et al. · Human Gene Therapy · 2010 · 922 citations

Vaccination, Molecular Virology, Allergy +12

224th ENMC International Workshop:

Yves Allenbach, Andrew L. Mammen, Olivier Benvéniste et al. · Neuromuscular Disorders · 2017 · 526 citations · Full text

Enmc International Workshop, Global Challenge, Performance Studies +1

Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies

K. Mariampillai, Benjamin Granger, Damien Amelin et al. · JAMA Neurology · 2018 · 422 citations · Full text

Immune checkpoint inhibitor-related myositis and myocarditis in patients with cancer

Mehdi Touat, Thierry Maisonobe, Omar Ben Hadj Salem et al. · Neurology · 2018 · 324 citations

Long-term observational study of sporadic inclusion body myositis

Olivier Benvéniste, Marguerite Guiguet, John Freebody et al. · Brain · 2011 · 305 citations · Full text